Naloxone: FDA approves over-the-counter Narcan nasal spray, with Bobby Mukkamala, MD
Bobby Mukkamala, MD, chair of the AMA Substance Use and Pain Care Task Force, joins to discuss what FDA's recent approval of OTC naloxone means for doctors and patients—as well as how to administer Narcan in an emergency. The life-saving medication can reverse an overdose from fentanyl, oxycodone and other opioids. American Medical Association CXO Todd Unger hosts. Visit https://end-overdose-epidemic.org for more information on AMA’s efforts to end the overdose epidemic.
Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Bobby Mukkamala, MD, chair of the AMA Substance Use and Pain Care Task Force, joins to discuss what FDA's recent approval of OTC naloxone means for doctors and patients—as well as how to administer Narcan in an emergency. The life-saving medication can reverse an overdose from fentanyl, oxycodone and other opioids. American Medical Association CXO Todd Unger hosts. Visit https://end-overdose-epidemic.org for more information on AMA’s efforts to end the overdose epidemic.